Welcome to our dedicated page for RISE GOLD news (Ticker: $RYES), a resource for investors and traders seeking the latest updates and insights on RISE GOLD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RISE GOLD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RISE GOLD's position in the market.
Rise Gold Corp. has granted over 1 million stock options to directors and an officer of the Company at a price of US$0.17 per share, expiring in 2029.
Rise Gold Corp. (CSE: RISE) has closed the second and final tranche of a non-brokered private placement, raising a total of US$954,253 through the sale of 10,044,765 units. The company previously closed the first tranche on April 9, 2024, raising US$545,902. Certain directors purchased 2,495,793 units, constituting a 'related party transaction.' Rise Gold plans to utilize the proceeds for general working capital, debt repayment, and settlement of related party fees.